Amgen showcases “excellent” data for its small-cell lung cancer treatment following leaked results for Moderna and Merck’s intismeran autogene.

A breakthrough treatment has made significant progress, showing promising results in decreasing recurrence and death from a ...

A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.

After sitting through the full presentation on the Phase 3 INTerpath-001 trial at the ESMO Congress over the weekend, ...